You just read:

Spark Therapeutics and Genable Technologies Announce Collaboration to Advance a Gene Therapy Treatment for a Rare Form of Retinitis Pigmentosa

News provided by

Spark Therapeutics

25 Mar, 2014, 04:00 GMT